Chronic Fatigue Syndrome (ME/CFS)
A complex, debilitating disorder characterized by profound fatigue that doesn't improve with rest and worsens with physical or mental activity.
TL;DR
ME/CFS requires six months of disabling fatigue plus post-exertional malaise — a delayed, disproportionate crash after activity. That feature is the diagnostic hallmark and the reason graded exercise can cause harm. Pacing within an energy envelope is the foundation of management.
Overview
Myalgic encephalomyelitis, also called chronic fatigue syndrome, is a serious, multi-system illness that has been misunderstood for decades and is still frequently misdiagnosed as depression or deconditioning. The Institute of Medicine criteria require three core features present for at least six months: substantial reduction in the ability to engage in pre-illness activity accompanied by fatigue, post-exertional malaise, and unrefreshing sleep — plus either cognitive impairment or orthostatic intolerance. Post-exertional malaise is the defining feature and separates ME/CFS from every other fatiguing condition. It is not simply tiredness after exertion. It is a delayed, disproportionate worsening of the whole symptom complex — fatigue, pain, cognitive dysfunction, flu-like malaise — typically appearing twelve to forty-eight hours after activity and lasting days or weeks. Crucially, the triggering activity can be trivial: a shower, a conversation, reading. This has direct treatment consequences. Two-day cardiopulmonary exercise testing demonstrates a reproducible abnormality in ME/CFS that does not occur in deconditioning: performance on the second day is worse than the first, indicating impaired recovery rather than lack of fitness. Graded exercise therapy, once standard, has been removed from major guidance including NICE after evidence of harm, and pacing — staying within an energy envelope — is the recommended approach. Onset frequently follows infection. Epstein-Barr virus, Ross River virus, Q fever, influenza and SARS-CoV-2 have all been documented triggers, and a substantial share of long COVID cases meet ME/CFS criteria. There is no diagnostic test and no approved treatment. Management is symptomatic: pacing, treating orthostatic intolerance, addressing sleep and pain, and avoiding the push-crash cycle.
Common Symptoms
- •Post-exertional malaise 12-48 hours after physical, cognitive or emotional exertion
- •Profound fatigue not relieved by rest, lasting over six months
- •Unrefreshing sleep despite adequate hours
- •Cognitive impairment — brain fog, slowed processing, word-finding difficulty
- •Orthostatic intolerance — dizziness or symptom worsening on standing
- •Widespread muscle and joint pain
- •Headaches of a new type or pattern
- •Sore throat and tender lymph nodes
- •Sensitivity to light, sound and certain foods
Common Causes
- •Post-viral onset — Epstein-Barr virus, enteroviruses, Ross River virus, Q fever, SARS-CoV-2
- •Immune dysregulation with altered cytokine profiles and natural killer cell dysfunction
- •Mitochondrial and bioenergetic impairment
- •Autonomic nervous system dysfunction, frequently with POTS
- •Hypothalamic-pituitary-adrenal axis abnormalities
- •Genetic susceptibility
- •Physical trauma or major surgery as a trigger in a minority
Root Causes
No single mechanism explains ME/CFS, and the most credible current model is a persistent dysregulated state triggered by an initial insult, usually infection, in a genetically susceptible person. Immune findings are among the most consistent: reduced natural killer cell cytotoxicity has been replicated repeatedly, and altered cytokine profiles have been reported, particularly early in illness. Whether these are causal or downstream remains unresolved. Bioenergetic abnormalities are also well documented. Studies show impaired ATP production in peripheral blood mononuclear cells, abnormal metabolomic signatures resembling a hypometabolic state, and the two-day cardiopulmonary exercise test abnormality — a reproducible failure to reproduce day-one performance on day two, which does not occur in sedentary controls or in depression. Autonomic dysfunction is common enough to be diagnostically useful. Postural orthostatic tachycardia syndrome coexists in a large minority, and cerebral blood flow reductions on standing have been demonstrated in ME/CFS patients even without meeting POTS criteria. Importantly, deconditioning does not explain the picture. Patients frequently develop the illness while highly active, and the day-two exercise test abnormality distinguishes ME/CFS from deconditioning directly.
How It's Diagnosed
Diagnostic Markers
- No diagnostic biomarker exists — diagnosis is clinical against IOM or Canadian Consensus criteria
- Full blood count, ferritin, TSH, B12, folate, coeliac serology to exclude alternatives
- HbA1c, liver and kidney function
- CRP and ESR
- Cortisol and morning testing where adrenal insufficiency is suspected
- Active stand test or tilt table for orthostatic intolerance and POTS
- Sleep study where apnoea is plausible
- Two-day cardiopulmonary exercise testing in research settings only — it can provoke severe relapse
When to See a Doctor
See a doctor for fatigue lasting over six months with post-exertional worsening, particularly following an infection. Seek prompt review for new neurological signs, unexplained weight loss, fever, night sweats or swollen lymph nodes that persist, all of which point to alternative diagnoses requiring investigation.
Supplements Studied For This
NADH
One small randomized trial found that 10-20 mg/day of stabilized NADH reduced chronic fatigue syndrome symptom severity compared with placebo, and NADH is mechanistically plausible given the mitochondrial dysfunction reported in ME/CFS. However, this remains a single small trial awaiting replication.
CoQ10
The mitochondrial rationale for CoQ10 in ME/CFS is coherent and small trials of CoQ10 with NADH have shown modest fatigue reductions. The evidence base is too small and too short to promise anything, but it is safe and worth a defined trial.
L-Carnitine
L-carnitine improved fatigue scores in early chronic fatigue trials, but the evidence is old, small and largely unreplicated.
Magnesium
Interest in magnesium for ME/CFS dates to a small 1991 trial reporting improved energy after intramuscular injection. That result has not been reliably replicated with oral dosing, so the case rests largely on correcting documented deficiency.
B-Complex Vitamins
In diagnosed ME/CFS, B-complex is supportive housekeeping rather than treatment. It corrects deficiency; it does not address post-exertional malaise.
Rhodiola Rosea
Reasonable to trial for daytime energy alongside pacing, but it is not a treatment for ME/CFS and must not be used to justify pushing past your energy envelope.
Diet & Lifestyle
Suggested Pattern
No diet treats ME/CFS. The practical priorities are maintaining adequate energy and protein intake despite reduced appetite and cooking capacity, managing common comorbid problems such as IBS and orthostatic intolerance, and avoiding restrictive diets that add burden without evidence. For orthostatic intolerance, increased salt and fluid intake is often recommended, unlike general dietary advice.
Eat more
- Regular small meals to avoid the energy cost of large ones
- Adequate protein at each meal
- Increased salt and fluids if orthostatic intolerance is present
- Easy-to-prepare or batch-cooked foods — cooking is itself an exertion
- Oily fish and other anti-inflammatory foods
- Adequate total calories; unintentional undereating is common
Avoid
- Alcohol, which many patients become markedly intolerant of
- Excessive caffeine, which borrows energy and worsens sleep
- Large heavy meals, which can trigger post-prandial crashes
- Restrictive elimination diets without a clear indication
- Skipping meals due to fatigue, which compounds the problem
Supporting Research
Effects of acute and 14-day coenzyme Q10 supplementation on exercise performance in both trained and untrained individuals
Rhodiola rosea for physical and mental fatigue: a systematic review
Chronic fatigue syndrome post-COVID-19: triple-blind randomised clinical trial of Astragalus root extract
Randomized controlled trial of Siberian ginseng for chronic fatigue
Effect of coenzyme Q10 plus NADH supplementation on fatigue perception and health-related quality of life in myalgic encephalomyelitis/chronic fatigue syndrome
Frequently Asked Questions
Who It Affects
Estimates range from 0.2% to 0.4% of the population, though post-COVID cases have increased this substantially in recent years. Around 75% of patients are unable to work full-time and roughly 25% are housebound or bedbound. Full recovery is uncommon, though improvement is possible.
Women are affected roughly two to four times more often than men. Onset peaks between ages 10-19 and 30-39. All ethnic groups are affected, though diagnosis rates are lower in minority and lower-income populations, likely reflecting access rather than true incidence.
Quick Facts
- •Post-exertional malaise is the diagnostic hallmark, not fatigue alone
- •Two-day exercise testing shows worse performance on day two — unique to ME/CFS
- •NICE removed graded exercise therapy from its guidance after evidence of harm
- •Around 25% of patients are housebound or bedbound
- •A substantial share of long COVID cases meet ME/CFS criteria
Lifestyle Tips
- •Learn pacing — stay within your energy envelope rather than pushing through
- •Stop activity before you feel you need to, not when you are exhausted
- •Use a heart rate monitor with an anaerobic threshold ceiling if that helps you pace
- •Break tasks into short blocks with rest between
- •Treat orthostatic intolerance with compression garments, salt, fluids and seated activity
- •Protect a consistent sleep window even though sleep is unrefreshing
- •Avoid the push-crash cycle — good days spent catching up cause the next crash
- •Seek a clinician familiar with current guidance; outdated advice is still common
My Notes
Sign in to add personal notes
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.